GNPX Stock Analysis: Buy, Sell, or Hold?
GNPX - Genprex, Inc. Common Stock
$4.02
0.07 (1.77%)
▲
5d:
-10.17%
30d:
-48.53%
90d:
+389.59%
HOLD
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When GNPX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GNPX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GNPX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GNPX is currently trading at $4.02, which is considered slightly low relative to its 30-day fair value range of $2.76 to $7.59.
Technical Outlook: Technically, GNPX is in a strong downtrend. Immediate support is located at $3.83, while resistance sits at $5.24.
Market Sentiment: GNPX scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.50 (+89.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GNPX is in a strong downtrend. Immediate support is located at $3.83, while resistance sits at $5.24.
Market Sentiment: GNPX scores 86/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $7.50 (+89.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.76 -
$7.59
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (86/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 89.9% below Wall St target ($7.50)
- CAUTION: Bottoming setup, but lagging the sector by 48% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-10.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.76 -
$7.59
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.83
Resistance Level
$5.24
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.43
Wall Street Target
$7.50
(+89.9%)
Share & Embed Analysis
Last updated: August 24, 2026 4:40 PM ET
Data refreshes hourly during market hours. Next update: 5:40 PM
Data refreshes hourly during market hours. Next update: 5:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GNPX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Brent M Longnecker
SELL
8 shares
2026-04-14
Brent M Longnecker
SELL
10 shares
2026-04-14
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 42 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 38 SELL |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$560 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
